-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Akero Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2019 to 2023.
- Akero Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 69.2M shares, a 33.3% increase year-over-year.
- Akero Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 52.6M shares, a 34.8% increase from 2022.
- Akero Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 39M shares, a 11.9% increase from 2021.
- Akero Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 34.8M shares, a 10.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)